Whitepaper: Risk-Based Quality Management (RBQM)
📄 About This Document
Learn how Risk-Based Quality Management (RBQM) can enhance the quality, efficiency, and oversight of clinical trials. This one-pager outlines the key principles of RBQM, its core components, and insights from a case study on SDV in neurodegenerative studies.
📥 Download the full document to explore how RBQM strategies can optimize your clinical projects.
Related
Julius Clinical Welcomes Bassem Saleh as Chief Executive Officer
Zeist, The Netherlands – September 23, 2025 – Julius Clinical, a leading clinical Contract Research Organization (CRO) with deep therapeutic expertise in CNS and Cardiometabolic diseases, is pleased to announce the appointment of Bassem Saleh ...
Julius Clinical Expands CNS and Cardiometabolic Capabilities with Post-Merger Growth and New Operations in Spain and Germany
Zeist, The Netherlands – [Date] – Julius Clinical, a leading clinical Contract Research Organization (CRO) with deep therapeutic expertise in CNS and Cardiometabolic indications, today announced continued growth in bookings in these key therap...
Is MASH the most silent disease everyone is talking about?
Interview 3rd June 2025Julius Clinical sat down with Professor Helena Cortez-Pinto (MD, PhD), a gastroenterology and hepatology specialist with a particular interest in steatotic liver disease, nutrition, and public health, to talk about metab...
